| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/bmcbi/LiuHLXLKWL17 |
| P6179 | Dimensions Publication ID | 1100103607 |
| P356 | DOI | 10.1186/S12859-017-1891-6 |
| P932 | PMC publication ID | 5751793 |
| P698 | PubMed publication ID | 29297280 |
| P2093 | author name string | Li He | |
| Zhichao Liu | |||
| Yuan Liu | |||
| Menglong Li | |||
| Zhining Wen | |||
| Keqin Liu | |||
| Qifan Kuang | |||
| Junmei Xu | |||
| P2860 | cites work | RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer | Q24291637 |
| Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus | Q24304627 | ||
| KEGG: Kyoto Encyclopedia of Genes and Genomes | Q24548371 | ||
| Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 | ||
| Emerging patterns of somatic mutations in cancer | Q27014126 | ||
| Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation | Q27851447 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists | Q28131785 | ||
| CA125 and UQCRFS1 FISH studies of ovarian carcinoma | Q28181452 | ||
| Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples | Q28253011 | ||
| Comprehensive analysis of 19q12 amplicon in human gastric cancers. | Q53629713 | ||
| Endometrial cancer | Q63199203 | ||
| The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study | Q72368481 | ||
| Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas | Q72810167 | ||
| The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways | Q73459314 | ||
| Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis | Q74116705 | ||
| Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas | Q74757496 | ||
| Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers | Q83414403 | ||
| Integrated genomic characterization of endometrial carcinoma | Q28289962 | ||
| Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
| ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
| Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm | Q29547194 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| COSMIC: exploring the world's knowledge of somatic mutations in human cancer | Q29615725 | ||
| Fibroblast growth factor signalling: from development to cancer | Q29616827 | ||
| Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution | Q29619477 | ||
| VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data | Q30754874 | ||
| Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling. | Q30802729 | ||
| Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes | Q30883788 | ||
| TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling | Q33613510 | ||
| The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer | Q33740655 | ||
| Molecular profiling of endometrial malignancies | Q33757898 | ||
| Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. | Q33983489 | ||
| Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients | Q34059934 | ||
| Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma | Q34354361 | ||
| NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer | Q34794640 | ||
| Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis | Q35750136 | ||
| Prognostic parameters of endometrial carcinoma | Q35799482 | ||
| Development of prognostic signatures for intermediate-risk papillary thyroid cancer | Q36134855 | ||
| Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH). | Q36621668 | ||
| Drug-sensitive FGFR2 mutations in endometrial carcinoma | Q36735178 | ||
| Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer. | Q36930858 | ||
| Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation | Q37140110 | ||
| Use of mutation profiles to refine the classification of endometrial carcinomas. | Q37612253 | ||
| Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. | Q37736934 | ||
| Markers for individualised therapy in endometrial carcinoma | Q38030768 | ||
| Classification of endometrial carcinoma: more than two types | Q38215703 | ||
| Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma | Q38760287 | ||
| Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis | Q39721070 | ||
| Adipocytokines levels at delivery, functional variation of TFAP2β, and maternal and neonatal anthropometric parameters | Q44582625 | ||
| Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3. | Q45087021 | ||
| Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. | Q45966811 | ||
| Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer | Q46056223 | ||
| Expression profiles of osteosarcoma that can predict response to chemotherapy. | Q46706109 | ||
| Using variable combination population analysis for variable selection in multivariate calibration. | Q50958906 | ||
| hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer. | Q51680757 | ||
| Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation. | Q53380672 | ||
| P433 | issue | Suppl 14 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 472 | |
| P577 | publication date | 2017-12-28 | |
| P1433 | published in | BMC Bioinformatics | Q4835939 |
| P1476 | title | Mutation status coupled with RNA-sequencing data can efficiently identify important non-significantly mutated genes serving as diagnostic biomarkers of endometrial cancer | |
| P478 | volume | 18 |
| Q47107648 | Proceedings of the 2017 MidSouth Computational Biology and Bioinformatics Society (MCBIOS) Conference | cites work | P2860 |
Search more.